Schools and drugs: health and social responses
A new handy mini guide by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on evidence-based policymaking for prevention of drug use in schools and educational settings.
EMCDDA
European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply
Today, the European Commission has adopted measures to control two harmful new psychoactive substances (NPS) across the EU. The substances in question — 3-methylmethcathinone (3-MMC) and 3-chloromethcathinone (3-CMC) — are both synthetic...
Findings from the European Web Survey on Drugs 2021
We take a look at the top level findings from this anonymous survey run annually by EMCDDA and its partners. The survey reveals that cannabis and ecstasy use are the drug-consumption patterns most impacted by COVID-19 restrictions.
EMCDDA launches PLATO e-learning platform and virtual community of practice
PLATO, a multilingual integrated platform, is designed to facilitate online training, e-learning and discussion through a virtual community of practice (VCP). At present, PLATO hosts the European Prevention Curriculum (EUPC), a programme...
EMCDDA best practice portal
EMCDDA's best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration. It will help you identify tried...
Health and social responses to cannabis problems in Europe — time for a paradigm shift?
Objective: This is the first EMCDDA webinar in the cannabis webinar series, which opens the debate with an all-encompassing overview of the key issues and response options available. Background: Cannabis is the most widely used illicit drug...
Implementing quality standards for drug services and systems: a six-step guide to support quality assurance
This publication provides a practical introduction to the area of quality standards and quality assurance mechanisms and the key steps involved in their implementation in drug services and systems.
Manual: increasing access to hepatitis C testing and care for people who inject drugs
This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs.
EMCDDA Strategy 2025
This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better-informed drug policy and action. Adopted unanimously by the agency’s key...
Drug-Related Homicide in Europe: A First Review of the Data and Literature
EMCDDA, Lisbon, May 2018 Series type: EMCDDA Papers Summary Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime...
